Senior insider sale
Senior VP, Chief Legal Officer at BIOCRYST PHARMACEUTICALS INC — senior position signals high conviction
$1.49M
204.66K shares
What this filing means
BARNES ALANE P plans to sell 204.66K shares of BIOCRYST PHARMACEUTICALS INC valued at approximately $1.49M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/22/2025ACC: 0001959173-25-007875
Officer· Senior VP, Chief Legal Officer
Since Nov 2018
204.66K
Shares to sell
$1.49M
Approx. market value
21.77K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
12/19/2025
21.77KTotal acquired21.77K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/19/2025 | Restricted Stock Vesting Compensation | 21.77K | — |
| Total | 21.77K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
21.21K
Market value
$162.3K
12/15/2025
—Completed
Units to sell
19.77K
Market value
$151.2K
12/3/2025
—Completed
Units to sell
50.91K
Market value
$367.2K
12/2/2025
—Completed
Units to sell
91K
Market value
$646.5K
12/1/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
21.77K
Market value
$166.6K
12/22/2025
Total
Units
204.66K
Value
$1.49M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/15/2025 | 21.21K | $162.3K | — | Completed |
12/3/2025 | 19.77K | $151.2K | — | Completed |
12/2/2025 | 50.91K | $367.2K | — | Completed |
12/1/2025 | 91K | $646.5K | — | Completed |
| Planned — Approximate Date | ||||
12/22/2025 | 21.77K | $166.6K | NASDAQ | Planned |
| Total | 204.66K | $1.49M | ||